Anlon Healthcare Limited (AHCL) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE0Y8W01017
Key metrics
- Market Cap
- ₹846 Cr
- P/E Ratio
- 22.41
- EPS
- 0.71
- Book Value
- 4.79
- P/B Ratio
- 3.26
- ROE
- 11.19%
- ROCE
- 15.5%
- Debt / Equity
- 0.17
- Net Margin
- 16.58%
- Revenue Growth
- 42.96%
- Profit Growth
- 38.97%
- Dividend Yield
- —
- 52W High
- ₹17.27
- 52W Low
- ₹9.08
- Market Cap Band
- small cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Anlon Healthcare Limited
Anlon Healthcare Limited manufactures and sells active pharmaceutical ingredients in India and internationally. The company also offers bulk drugs; advanced pharmaceutical intermediates; nutraceutical API products; and drug intermediates. It also manufactures loxoprofen sodium dihydrate, ketoprofen, and dexketoprofen trometamol products for pain management and anti-inflammatory therapies. Anlon Healthcare Limited was incorporated in 2013 and is based in Rajkot, India.
- Headquarters
- Rajkot, India
- Employees
- 119
- Promoter Holding
- 79.32%
The full Anlon Healthcare Limited analysis
Create a free account to open the complete AHCL deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.